Recruiting First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors NCT07284186 Conditions Adenocarcinoma, Adenocarcinoma Of Esophagus, Advanced Solid Tumor, +35 more Locations Research Site — Scottsdale, Arizona, United States Research Site — Duarte, California, United States Research Site — Orange, California, United States Research Site — Boston, Massachusetts, United States View more locations Show fewer locations Loading locations... View Trial Details
Completed Pembrolizumab and Palliative Radiation Therapy in Treating Patients With Metastatic Esophagus, Stomach, or Gastroesophageal Junction Cancer NCT02830594 Conditions Adenocarcinoma Of Esophagus, Carcinoma, Carcinoma, Squamous Cell, +19 more Locations City of Hope Medical Center — Duarte, California, United States View Trial Details
Completed Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer NCT01178944 Conditions Adenocarcinoma Of Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Carcinoma, +32 more Locations Roswell Park Cancer Institute — Buffalo, New York, United States Rochester General Hospital — Rochester, New York, United States View Trial Details
Active, Not Recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors NCT02834013 Conditions Acinar Cell Carcinoma, Adenocarcinoma, Adenocarcinoma of Lung, +207 more Locations University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States University of South Alabama Mitchell Cancer Institute — Mobile, Alabama, United States Anchorage Associates in Radiation Medicine — Anchorage, Alaska, United States Anchorage Radiation Therapy Center — Anchorage, Alaska, United States View all 1007 locations View more locations Show fewer locations Loading locations... View Trial Details
